Public company intelligence preview
TURNING POINT BRANDS INC
116 insider trades surfaced from the last year. This page shows only aggregate signals, not the underlying transactions, people, filings, filters, or AI workspace.
Snapshot
A narrow read on a much deeper workspace.
The preview gives search visitors enough signal to understand coverage. It does not expose transaction records, person-level profiles, filters, comparisons, or analyst workflows.
Insider compensation
Public aggregate: $1.4M average total compensation across covered insiders.
Governance movement
Public aggregate: 0 governance events in the last year.
Institutional ownership
Public aggregate: 244 holders from the latest quarter.
Restricted sales and governance
Public counts, not the investigation layer.
The full product opens the underlying filings, insider context, historical holdings, comparison tools, and AI analysis.
Market context
Basic quote context for the preview.
Company note
Context before the data.
Company Overview
Turning Point Brands, Inc. (NYSE: TPB) operates in the Consumer Defensive sector and Tobacco industry, with a business focused on adult-use alternative smoking accessories and other tobacco products. Its core brands include Zig-Zag and Stoker’s, while newer offerings such as FRE and ALP expand the company into modern oral nicotine through a joint venture. The company has a largely North American footprint, with more than 90% of 2025 net sales generated in the U.S. and the balance mainly in Canada. Its asset-light model, broad retail distribution, and strong cash generation are central to how the business operates.
Executive Compensation Practices
For a company like TPB, executive compensation is likely driven by a mix of revenue growth, gross margin expansion, operating income, and cash flow conversion, with additional weight on successful expansion in higher-margin modern oral products. The 2025 results suggest incentive plans may be especially sensitive to Stoker’s performance, as that segment delivered the bulk of sales and profit growth, while Zig-Zag faced decline and tariff/mix pressure. Stock-based compensation is also a meaningful expense for the company, indicating equity awards are an important part of executive pay and retention. In the Tobacco industry, pay structures often emphasize regulatory execution, compliance spending, and product portfolio shifts, since FDA/PMTA-related milestones and successful commercialization can materially affect long-term value.
Insider Trading Considerations
Insider trading activity in TPB should be viewed through the lens of a company with recurring consumer demand, regulatory risk, and rapid product-mix changes. Trading may cluster around earnings releases, FDA/PMTA updates, tariff developments, or announcements related to modern oral expansion, since these events can significantly change expectations for margins and growth. Because TPB’s results are increasingly driven by the Stoker’s segment and joint-venture-related costs, insiders may react to signals about oral nicotine uptake, supply chain stability, and regulatory approvals. Researchers should also note that the company has significant intangible asset value and acquisition/joint venture activity, so insider transactions may reflect confidence or concern about integration, impairment risk, or future cash flow durability rather than just near-term sales trends.
Unlock the full TPB insider intelligence workspace.
Move from public aggregate counts into transaction-level detail, people, filings, compensation history, ownership shifts, export tools, and AI-assisted analysis.